Meet selectION, Inc. at the BIO International Convention in San Diego, CA, on June 22nd-25th, 2026
SAN DIEGO, May 12, 2026 – Meet selectION’s management team for an update on si-544, selectION’s best-in-class Kv1.3 ion channel blocker in development as a disease-modifying treatment for T cell-mediated…
Read More